James Khaling And Sons Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Chandel, Manipur, India, established in 2021.
2021 Chandel, Manipur, India Active
Last Updated:
Access Report
About James Khaling And Sons Pharmaceuticals Private Limited

James Khaling And Sons Pharmaceuticals Private Limited, a active private limited company, was established on 28 September 2021 in Chandel, Manipur, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230MN2021PTC014385. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shangkhubi Nangsha (Director), Khaling Milan (Managing Director). It is based at House No. 04, Khangshim Village, Machi Sub-Division,, Chandel, Manipur, 795135.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MN2021PTC014385

  • Registration Number

    014385

  • Incorporation Date

    28 September 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Guwahati

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 6 Months
Company report

James Khaling And Sons Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into James Khaling And Sons Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at James Khaling And Sons Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shangkhubi Nangsha Director 28 Sep 2021 Current
Khaling Milan Managing Director 28 Sep 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of James Khaling And Sons Pharmaceuticals.

Enhance accessibility to James Khaling And Sons Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

James Khaling And Sons Pharmaceuticals revenue growth over time
James Khaling And Sons Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of James Khaling And Sons Pharmaceuticals?

Unlock access to James Khaling And Sons Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at James Khaling And Sons Pharmaceuticals?

James Khaling And Sons Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of James Khaling And Sons Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped James Khaling And Sons Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on James Khaling And Sons Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Shangkhubi Nangsha was appointed as a Director was appointed as a Director on 28 Sep 2021 & has been associated with this company since 4 years 6 months . was completed.

  • Director Appointment

    The activity Khaling Milan was appointed as a Managing Director was appointed as a Managing Director on 28 Sep 2021 & has been associated with this company since 4 years 6 months . was completed.

  • Company Incorporation

    James Khaling And Sons Pharmaceuticals Private Limited was registered on 28 Sep 2021 with Roc Guwahati & aged 4 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of James Khaling And Sons Pharmaceuticals Private Limited?

The CIN of James Khaling And Sons Pharmaceuticals Private Limited is U24230MN2021PTC014385.

Where is James Khaling And Sons Pharmaceuticals Private Limited headquartered?

James Khaling And Sons Pharmaceuticals Private Limited is headquartered at House No. 04, Khangshim Village, Machi Sub-Division,, Chandel, Manipur, 795135.

When was James Khaling And Sons Pharmaceuticals Private Limited incorporated?

James Khaling And Sons Pharmaceuticals Private Limited was incorporated on 28 September 2021.

Who are the current directors of James Khaling And Sons Pharmaceuticals Private Limited?

The current directors of James Khaling And Sons Pharmaceuticals Private Limited are

What is the primary industry of James Khaling And Sons Pharmaceuticals Private Limited?

The primary industry of James Khaling And Sons Pharmaceuticals Private Limited is Chemicals.

Is James Khaling And Sons Pharmaceuticals Private Limited a listed company?

James Khaling And Sons Pharmaceuticals Private Limited is unlisted.

What is the capital structure of James Khaling And Sons Pharmaceuticals Private Limited?

The authorized capital of James Khaling And Sons Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available